BioCentury | Apr 30, 2012
Company News

Marina Biotech, Cambridge Biolabs LLC deal

...returned rights to use Marina's transKingdom RNAi (tkRNAi) delivery technology for agriculture and veterinary uses. Cambridge Biolabs...
...the technology for undisclosed veterinary applications, for which Marina is eligible for milestones and royalties. Cambridge Biolabs...
...delivered using the tkRNAi technology (see BioCentury, March 21). Marina Biotech Inc. (OTCQX:MRNA), Bothell, Wash. Cambridge Biolabs LLC...
Items per page:
1 - 1 of 1
BioCentury | Apr 30, 2012
Company News

Marina Biotech, Cambridge Biolabs LLC deal

...returned rights to use Marina's transKingdom RNAi (tkRNAi) delivery technology for agriculture and veterinary uses. Cambridge Biolabs...
...the technology for undisclosed veterinary applications, for which Marina is eligible for milestones and royalties. Cambridge Biolabs...
...delivered using the tkRNAi technology (see BioCentury, March 21). Marina Biotech Inc. (OTCQX:MRNA), Bothell, Wash. Cambridge Biolabs LLC...
Items per page:
1 - 1 of 1